Class Action Filed Against Zonagen, Inc.
BALA CYNWYD, Pa.--(BUSINESS WIRE)--March 27, 1998--Notice is hereby given that a class action lawsuit was filed on March 26, 1998 in the Southern
District of Texas on behalf of all persons who purchased the common stock of Zonagen, Inc. (''Zonagen'' or the ''Company'') in the open market from May 27,
1997 through Jan. 13, 1998, inclusive (the ''Class Period'').
The complaint charges Zonagen (NASDAQ: ZONA - news) and certain of its officers and directors of the Company with violations of Sections 10(b) and 20(a) of
the Securities Exchange Act of 1934, by, among other things, issuing to the investing public false or misleading statements concerning the effectiveness and market
potential of Vasomax, Zonagen's experimental impotency drug.
Plaintiff seeks to recover damages on behalf of class members and is represented by the law firm of Schiffrin Craig & Barroway, LLP, who has significant
experience and expertise prosecuting class actions on behalf of investors and shareholders.
Schiffrin Craig & Barroway, LLP maintains offices in Bala Cynwyd, Pennsylvania, Buffalo Grove, Illinois and Voorhees, New Jersey and is active in major litigations
pending in federal and state courts throughout the United States.
If you are a member of the class described above, you may, not later than May 8, 1998, move the Court to serve as lead plaintiff of the class, if you so choose. In
order to serve as lead plaintiff, however, you must meet certain legal requirements.
If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Schiffrin Craig
& Barroway, LLP (Andrew L. Barroway, Esq.) toll free at 888/299-7706 or 610/667-7706, or via e-mail at classlaw@ix.netcom.com. |
